Angiopoietin-2/angiopoietin-1 as non-invasive biomarker of cirrhosis in chronic hepatitis C-Reference-Cited by-同舟云学术

Angiopoietin-2/angiopoietin-1 as non-invasive biomarker of cirrhosis in chronic hepatitis C

Published:2016 Issue:44 Volume:22 Page:9744
ISSN:1007-9327
Container-title:World Journal of Gastroenterology
language:en
Short-container-title:WJG

Author:

Hernández-Bartolomé Ángel,López-Rodríguez Rosario,Borque María Jesús,González-Moreno Leticia,Real-Martínez Yolanda,García-Buey Luisa,Moreno-Otero Ricardo,Sanz-Cameno Paloma

Publisher

Baishideng Publishing Group Inc.

Subject

Gastroenterology,General Medicine

Reference44 articles.

1. Diagnosis, management, and treatment of hepatitis C: An update

2. EASL Clinical Practice Guidelines: Management of hepatitis C virus infection

3. Poynard T, Bedossa P. Age and platelet count: a simple index for predicting the presence of histological lesions in patients with antibodies to hepatitis C virus. METAVIR and CLINIVIR Cooperative Study Groups. J Viral Hepat 1997;4:199-208.

4. The history of the “natural history” of hepatitis C (1968-2009)

5. Chronic hepatitis C: This and the new era of treatment

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Impact of Liver Steatosis on Interleukin and Growth Factors Kinetics during Chronic Hepatitis C Treatment;Journal of Clinical Medicine;2024-08-16

2. New Biomarkers in Liver Fibrosis: A Pass through the Quicksand?;Journal of Personalized Medicine;2024-07-29

3. Lipid metabolism in patients with chronic hepatitis C, non-alcoholic fatty liver disease and obesity under the influence of treatment;INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (Ukraine);2024-04-19

4. The Role of Stem Cell Factor, Epidermal Growth Factor and Angiopoietin-2 in HBV, HCV, HCC and NAFLD;Life;2022-12-09

5. Biochemical and genomic identification of novel biomarkers in progressive sarcoidosis: HBEGF, eNAMPT, and ANG-2;Frontiers in Medicine;2022-10-25